ショック(Shock):治療薬開発パイプライン動向2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVE41017647)
◆英語タイトル:Shock-Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVE41017647
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ショック(Shock):治療薬開発パイプライン動向2014]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるショック(Shock)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、ショック(Shock)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・ショック(Shock)の概要

・ショック(Shock)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・ショック(Shock)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・ショック(Shock)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Shock-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Shock. This report provides information on the therapeutic development based on the Shock dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Shock
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Shock pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Shock and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
• Complete Pipeline intelligence and complete understanding over therapeutics development for Shock
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Shock pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions


*** レポート目次(コンテンツ)***

Table of Contents
• Shock Overview
• Shock Pipeline Therapeutics
• Shock Therapeutics under Development by Companies
• Shock Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Shock Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Shock Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Shock Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Shock – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Shock – Discontinued Products
• Shock – Dormant Products
• Companies Involved in Therapeutics Development for Shock
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Shock, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Shock Assessment by Monotherapy Products
• Shock Assessment by Combination Products
• Shock Assessment by Route of Administration
• Shock Assessment by Stage and Route of Administration
• Shock Assessment by Molecule Type
• Shock Assessment by Stage and Molecule Type
• Shock Therapeutics – Discontinued Products
• Shock Therapeutics – Dormant Products
• Products under Development by Companies, 2014


List of Figures
• Number of Products under Development for Shock, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Shock Assessment by Monotherapy Products
• Shock Assessment by Combination Products
• Shock Assessment by Route of Administration
• Shock Assessment by Stage and Route of Administration
• Shock Assessment by Molecule Type
• Shock Assessment by Stage and Molecule Type


*** レポートのキーワード ***

ショック(Shock)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • ICT予算予測(小規模企業):イタリア保険業界 – ICT予算内訳予測
    Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of su …
  • 世界の小型自動車用ドアモジュール市場【2015年1月更新版】
    This latest just-auto report edition offers a global review of the OE door modules sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: [ul] [li]Automotive OE door modules market size estimates[/li] [li]Latest technologies and trends[/li] [li]Market …
  • 世界及び中国のレイン市場2016
    The 'Global and Chinese Rhein Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Rhein industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rhein manufacturers and is a valuable source …
  • 化粧の世界市場2021
    This report studies Maquillage in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering L'Oréal Dr.Ci:Labo Unilever(Murad) Shiseido Croda J …
  • DNAおよびジーンチップの世界市場:製品別(消耗品、計器)、用途別(がんの診断・治療、ドラッグデリバリー、ゲノム解析)最終用途別、セグメント予測
    The global DNA & gene chip market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., at an 11.4% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome st …
  • 世界の電力抵抗器市場2016
    The Global Power Resistors Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Power Resistors industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. …
  • コスマックス(COSMAX, INC.)企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 世界の硫酸バリウム市場2017
    Barium Sulfate Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, …
  • 株式会社トンソ電子(Dong Seo Electronics Co.)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 肥厚性瘢痕:世界の治験レビュー(2017年下半期版)
    Hypertrophic Scars Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, “Hypertrophic Scars Global Clinical Trials Review, H2, 2017" provides an overview of Hypertrophic Scars clinical trials scenario. This report provides top line data relating to the clinical trials …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVE41017647 )"ショック(Shock):治療薬開発パイプライン動向2014" (英文:Shock-Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。